Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Videos|April 20, 2022

Educating on RWE

Dr Richter delves into how we can better educate patients and physicians on RWE to improve decision-making.

Episodes in this series

multiple myeloma

EP. 1 Coming Soon: Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma

EP. 2 A Multiple Myeloma Overview

EP. 2 A Multiple Myeloma Overview

EP. 3 MM and Regimens for First- and Second-Line Treatment

EP. 3 MM and Regimens for First- and Second-Line Treatment

EP. 4 MM From the Payers’ Perspective

EP. 4 MM From the Payers’ Perspective

EP. 5 MM Healthcare Resource Utilization

EP. 5 MM Healthcare Resource Utilization

EP. 6 Decision Support Tools for MM

EP. 6 Decision Support Tools for MM

EP. 7 MM and the Limitations of RCT Data

EP. 7 MM and the Limitations of RCT Data

EP. 8 MM and Real-World Evidence

EP. 8 MM and Real-World Evidence

EP. 9 The Value of RWE in MM

EP. 9 The Value of RWE in MM

EP. 10 Incorporating RWE in MM Decision-Making

EP. 10 Incorporating RWE in MM Decision-Making

EP. 11 RWE Decision-Making Barriers

EP. 11 RWE Decision-Making Barriers

EP. 12 MM and Non-Comparative RWE

EP. 12 MM and Non-Comparative RWE

EP. 13 Educating on RWE

EP. 13 Educating on RWE

EP. 14 MM Unmet Needs

EP. 14 MM Unmet Needs

EP. 15 Incorporating RWE Into Future Decision-Making

EP. 15 Incorporating RWE Into Future Decision-Making

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Anti-VEGF Has Hit Its DME Ceiling: John Kitchens, MD

ByLaura Joszt, MA,John Kitchens, MD

July 27th 2026

Experts featured in this series.

Diagnosing Alzheimer's Disease Agitation: Triggers, Care Specialties, and the Role of Primary Care

ByKavita Nair, PhD,Anton Porsteinsson , MD,Alireza Atri, MD, PhD

Published: July 27th 2026 | Updated: July 16th 2026

Experts featured in this series.

Defining Alzheimer's Disease Agitation: Diagnostic Criteria, Symptoms, and Disease Course

ByKavita Nair, PhD,Anton Porsteinsson , MD,Alireza Atri, MD, PhD

Published: July 27th 2026 | Updated: July 16th 2026

David Zhang.

Polygenic Risk Scores Move Closer to IPF Clinical Use: David Zhang, MD

BySabrina McCrear,David Zhang, MD

July 24th 2026

FDA HHS - Tada Images - stock.adobe.com

FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis

ByPearl Steinzor

July 24th 2026

Trending on AJMC

Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029

FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis

Small Workflow Changes Close Big Gaps in CKM Screening

Fifth Death Confirmed in NYC Legionnaires' Outbreak

Pirtobrutinib Plus Venetoclax-Rituximab Cuts CLL Progression 45%